Scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs.
Artificial human organs, or organ-on-chip technologies, simulate a whole organ’s cell make up and physiology. They act as alternatives to animal models in drug safety testing, but until now they have not been used to test how infectious diseases interact with the organs.
Our work represents the next frontier in the use of this technology.
Dr Marcus Dorner Lead author
Now, researchers from Imperial are using this technology to determine how pathogens interact with artificial organs. They hope it will help us to better understand the resulting disease and develop new treatments.
In particular, the team used an artificial liver – originally developed at MIT, the University of Oxford, and biotechnology company CN Bio Innovations – and tested its response to hepatitis B virus infection.
Dr Marcus Dorner, lead author from Imperial’s Department of Medicine, said: “This is the first time that organ-on-a-chip technology has been used to test viral infections. Our work represents the next frontier in the use of this technology. We hope it will ultimately drive down the cost and time associated with clinical trials, which will benefit patients in the long run.”
Opportunities for future drug development
Hepatitis B virus is currently incurable, and affects over 257 million people worldwide. Development of a cure has been slow because there is no model system in which to test potential therapies.
However, the Imperial team showed that the liver-on-a-chip technology could be infected with hepatitis B virus at physiological levels and had similar biological responses to the virus as a real human liver, including immune cell activation and other markers of infection. In particular, this platform uncovered the virus’s intricate means of evading inbuilt immune responses – a finding which could be exploited for future drug development.
Although this technology is in its early stages, the researchers suggest that it might eventually enable patients to have access to new types of personalised medicine. Rather than using generic cells lines, doctors in the future could potentially use cells from an actual patient and test how they would react to certain drugs for their infection, which may make treatments more targeted and effective.
The benefits of using organs-on-chips
Organs-on-chips house live human cells on scaffolds that are physiologically, mechanically, and structurally similar to the emulated organ. Drugs or viruses are passed through the cells via tubes that simulate blood flow through the body. The living cells used in tests last much longer on the chip than in traditional laboratory methods, and require lower infection doses compared to traditionally used model systems.
Hepatitis B is very infectious and causes liver cancer and cirrhosis. Thus, the researchers say, it was the best virus to use for the first test as its interactions with the immune system and liver cells are complex, but with devastating consequences for the tissues.
Dr Dorner said: “Once we begin testing viruses and bacteria on other artificial organs, the next steps could be to test drug interaction with the pathogens within the organ-on-chip environment.”
Other organs-on-chips currently in use include the heart, kidneys, and lungs. The authors say using these artificial organs for human pathogens could help researchers to better understand the mechanisms of infectious disease, and to observe how the virus and cells in the organ interact. This could lead to new drugs and treatments for a number of diseases affecting different organs in the future.
The Latest on: Artificial human organs
via Google News
The Latest on: Artificial human organs
- New European longevity-focused venture fund LongeVC comes out of stealthon October 8, 2020 at 9:58 am
The first longevity medicine-focused venture capital fund in the Baltic countries LongeVC comes out of stealth with a portfolio of investments and announces its first successful exit. The organization ...
- Biology: Silk fibers improve bioink for 3D-printed artificial tissues and organson October 8, 2020 at 7:22 am
Photo: 3D printed constructs using hyaluronic acid-based inks free of silk fibroin nanofibers (-) and containing silk fibroin nanofibers (+). view more Credit Image: Osaka University Osaka, Japan – ...
- Silk fibers improve bioink for 3-D-printed artificial tissues and organson October 8, 2020 at 5:37 am
How do you test, in early-stage research, whether a potential pharmaceutical effectively targets a human tumor, organ, or some other part of the body? How do you grow a new hand or another body part?
- Penn researchers get $3.2 million grant to use artificial intelligence for improving heart transplantson October 7, 2020 at 11:46 am
A team of researchers at Penn Medicine are turning to artificial intelligence as a diagnostic tool to improve outcomes for patients who receive heart transplants. Each year, more than 2,000 heart ...
- How will CRISPR and gene-editing change the world? My long-read Q&A with Kevin Davieson October 6, 2020 at 4:31 am
Kevin Davies explores the amazing possibilities and difficult ethical questions involved with the rise of CRISPR and humanity's rapidly improving genome-editing capabilities.
- Researchers receive $3.2 million to use AI for improving heart transplant outcomeson October 5, 2020 at 2:03 pm
A team of researchers in the Perelman School of Medicine at the University of Pennsylvania, Case Western Reserve University, Cleveland Clinic, and Cedars-Sinai Medical Center, were recently awarded a ...
- Penn researchers receive grant to use AI to improve heart transplant outcomeson October 5, 2020 at 7:39 am
Researchers in the Perelman School of Medicine at the University of Pennsylvania were awarded a $3.2 million grant from the NIH to enhance research for improving heart transplant outcomes for patients ...
- New thermofluidic technology allows researchers to bioprint cells in 3Don October 1, 2020 at 4:41 am
Researchers have used heat to develop a new way to bioengineer cells to grow a certain way and bioprint 3D tissues.
- The heat is on for building 3-D artificial organ tissueson September 30, 2020 at 2:04 pm
Bioengineers are devising a hot new technology to remotely control the positioning and timing of cell functions to build 3-dimensional, artificial, living tissues.
- Biotech Company Plans to Manufacture Artificial Retinas in Spaceon September 30, 2020 at 7:49 am
"...we are continually bolstered by the great potential of [low-Earth orbit] for broader implications across industries." ...
via Bing News